Found: 4
Select item for more details and to access through your institution.
Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2023, v. 12, p. 1, doi. 10.3389/fcimb.2022.1064537
- By:
- Publication type:
- Article
Serum TGF-β1 and CD14 Predicts Response to Anti-TNF-α Therapy in IBD.
- Published in:
- Journal of Immunology Research, 2023, p. 1, doi. 10.1155/2023/1535484
- By:
- Publication type:
- Article
Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 3188, doi. 10.3390/cells10113188
- By:
- Publication type:
- Article
Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0277576
- By:
- Publication type:
- Article